Based on practice patterns in your community, what percentage of hospitalised medical patients at risk for venous thromboembolism (VTE) receive guideline-based thromboprophylaxis?
1) Less than 25%
2) 25–50%
3) 50–75%
4) More than 75%
1) |
2) |
3) |
4) |
While the results vary from country to country, the multinational ENDORSE registry shows only about 40% of hospitalised medical patients at risk for venous thromboembolism (VTE) receive thromboprophylaxis.
Learn more about the risk of VTE for hospitalised medical patients.
Which of the following characteristics of an “ideal” anticoagulant would you rate as the most important?
1) Oral administration
2) Single daily dose
3) No need for routine coagulation monitoring
4) Fast onset and offset
1) |
2) |
3) |
4) |
None of the anticoagulants in common use has all of the characteristics for an ideal anticoagulant listed above.
Learn more about new approaches in anticoagulation.
Think back to your medical education: how did learning about the details of coagulation compare to other topics of study?
1) More complex, harder to understand
2) Comparable to other topics
3) Less complex, easier to understand
1) |
2) |
3) |
For decades, coagulation was conceptualised as having two separate points of initiation: the extrinsic pathway and the intrinsic pathway. Over time, however, it has become clear that these pathways do not function in the body as parallel, independent systems.
Learn more about the current model of the coagulation cascade.
In your experience, after a patient is diagnosed with deep vein thrombosis (DVT) or pulmonary embolism (PE), which of the following long-term complications of venous thromboembolism (VTE) are you most concerned about?
1) Recurrent VTE
2) Post-thrombotic syndrome
3) Chronic thromboembolic pulmonary hypertension
1) |
2) |
3) |
VTE poses risks of intermediate- and long-term complications that include recurrent VTE with an associated risk of pulmonary embolism, post-thrombotic syndrome, and chronic thromboembolic pulmonary hypertension.
Learn more about long-term complications of DVT.






